发明名称 |
MULTIPLE AGENT DIABETES THERAPY |
摘要 |
A pharmaceutical composition includes at least two of agents I)- iii), wherein agent (i) is selected from the group consisting of an insulin, an insulin analog, a physiologically active fragment of said insulin and a physiologically active fragment of said insulin analog, agent (ii) is selected from the group consisting of an insulin-related peptide, an insulin-related peptide analog, a physiologically active insulin-related peptide fragment and a physiologically active insulin-related peptide analog fragment, and agent (iii) is an insulin sensitizer.
|
申请公布号 |
WO0100223(A3) |
申请公布日期 |
2001.05.25 |
申请号 |
WO2000US17268 |
申请日期 |
2000.06.23 |
申请人 |
MINIMED INC. |
发明人 |
VAN ANTWERP, WILLIAM, P.;PFUETZNER, ANDREAS, H., R. |
分类号 |
A61K9/10;A61K31/427;A61K38/28;A61K38/30;A61K45/00;A61K47/02;A61K47/04;A61K47/10;A61K47/34;A61M1/36;A61P3/10;(IPC1-7):A61K38/28 |
主分类号 |
A61K9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|